These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. mTOR signaling plays a critical role in the defects observed in muscle-derived stem/progenitor cells isolated from a murine model of accelerated aging. Takayama K; Kawakami Y; Lavasani M; Mu X; Cummins JH; Yurube T; Kuroda R; Kurosaka M; Fu FH; Robbins PD; Niedernhofer LJ; Huard J J Orthop Res; 2017 Jul; 35(7):1375-1382. PubMed ID: 27572850 [TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders. Evangelisti C; Cenni V; Lattanzi G Br J Clin Pharmacol; 2016 Nov; 82(5):1229-1244. PubMed ID: 26952863 [TBL] [Abstract][Full Text] [Related]
8. Longevity, aging and rapamycin. Ehninger D; Neff F; Xie K Cell Mol Life Sci; 2014 Nov; 71(22):4325-46. PubMed ID: 25015322 [TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin as a target in hematological malignancies. Kelly KR; Rowe JH; Padmanabhan S; Nawrocki ST; Carew JS Target Oncol; 2011 Mar; 6(1):53-61. PubMed ID: 21499765 [TBL] [Abstract][Full Text] [Related]
10. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment. Cao J; Huang W PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and the cellular response to rapamycin: potential role in diagnosis and therapy. Totary-Jain H; Marks AR Cell Cycle; 2013 Mar; 12(6):861-2. PubMed ID: 23442794 [No Abstract] [Full Text] [Related]
12. Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D. KrzeĊniak M; Zajkowicz A; Matuszczyk I; Rusin M Mech Ageing Dev; 2014 Jul; 139():11-21. PubMed ID: 24915467 [TBL] [Abstract][Full Text] [Related]
13. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth. Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247 [TBL] [Abstract][Full Text] [Related]
14. From rapalogs to anti-aging formula. Blagosklonny MV Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953 [TBL] [Abstract][Full Text] [Related]
15. Rapamycin: one drug, many effects. Li J; Kim SG; Blenis J Cell Metab; 2014 Mar; 19(3):373-9. PubMed ID: 24508508 [TBL] [Abstract][Full Text] [Related]
16. Rapalogs and mTOR inhibitors as anti-aging therapeutics. Lamming DW; Ye L; Sabatini DM; Baur JA J Clin Invest; 2013 Mar; 123(3):980-9. PubMed ID: 23454761 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond. Lamming DW Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048303 [TBL] [Abstract][Full Text] [Related]